• Sumatriptan Succinate Research Workflows

  2026-09-23

  Use Sumatriptan Succinate as a mechanistically defined 5-HT1 receptor agonist for migraine, neurogenic inflammation, and metabolism studies. This workflow emphasizes concentration control, orthogonal readouts, and parallel MAO/CYP testing so receptor biology is not confused with metabolite effects.

• GLP-1 (9-36) Amide in Translational Research

  2026-09-22

  A mechanistic and strategic guide to using GLP-1 (9-36) amide as a glucagon-like peptide-1 receptor antagonist in receptor signaling, metabolic regulation, and type 2 diabetes research. The article connects assay design, antagonist selection, peptide handling, and translational interpretation while distinguishing product-specific evidence from broader GLP-1 receptor biology.

• Pazopanib in ATRX-Deficient Glioma Research

  2026-09-22

  Pazopanib (GW-786034) provides a practical way to interrogate VEGFR, PDGFR, and FGFR signaling in biomarker-aware cancer research. This workflow connects ATRX-deficient glioma vulnerability with reproducible compound handling, combination testing, and translational angiogenesis models.

• DHHC9–STRN4 Palmitoylation Drives YAP Metastasis

  2026-09-21

  The reference study identifies DHHC9-mediated palmitoylation of STRN4 as an upstream mechanism that activates YAP and promotes adenocarcinoma migration and metastasis. Its genetic, proteomic, and pharmacological evidence positions the DHHC9–STRN4–YAP axis as a tractable framework for studying palmitoylation-directed cancer therapy, while leaving important questions about inhibitor selectivity and translational feasibility.

• Gepotidacin in EAGLE-2 and EAGLE-3 UTI Trials

  2026-09-21

  The EAGLE-2 and EAGLE-3 phase 3 trials evaluated Gepotidacin, also known as GSK2140944, against nitrofurantoin for uncomplicated urinary tract infection. Gepotidacin met the prespecified non-inferiority criterion in both studies and was superior in EAGLE-3, supporting further evaluation of an oral antibiotic that acts through a distinct bacterial topoisomerase pathway.

• Cell Adhesion Barriers in Interspecies Chimerism

  2026-09-20

  Ballard et al. identify interspecies cell-adhesion incompatibility as a distinct xenogeneic barrier that limits human pluripotent stem cell contribution to mouse embryos. Their surface-displayed nanobody–antigen system improves heterospecific adhesion in vitro and increases human cell chimerism, providing a synthetic strategy for studying early interspecies development.

• Cy3 TSA Fluorescence System Kit for Liver Cancer Biology

  2026-09-19

  The Cy3 TSA Fluorescence System Kit converts HRP activity into localized, high-density fluorescence for challenging IHC, ICC, and ISH targets. This workflow-focused guide shows how to apply a TSA fluorescence kit to liver cancer studies involving SIX1, lipogenic enzymes, and regulatory RNA while controlling background and quantification bias.

• GI 254023X: Practical ADAM10 Inhibitor Workflows

  2026-09-18

  GI 254023X combines nanomolar ADAM10 potency with strong ADAM17 selectivity, enabling cleaner studies of sheddase-dependent signaling, endothelial barrier failure, and Jurkat-cell phenotypes. This guide translates its product specifications and published model data into practical assay workflows, controls, and troubleshooting decisions.

• Primary Antibody Dilution Buffer: PCNSL Workflows

  2026-09-18

  Learn how Primary Antibody Dilution Buffer SKU K1200 can support controlled IHC, ICC, and ISH validation alongside cell viability, proliferation, and cytotoxicity assays. This scenario-based guide connects buffer selection, antibody titration, storage, and interpretation with recent PCNSL metabolic findings.

• Lypressin Acetate: From Receptor Biology to Translation

  2026-09-17

  Lypressin acetate is more than a historical antidiuretic peptide: it is a useful translational reference for connecting vasopressin receptor pharmacology, activity-unit interpretation, vasoconstriction research, and carefully staged antiviral hypothesis testing.

• Oteseconazole: DDI-Aware Candida Research

  2026-09-17

  Oteseconazole (VT-1161) is more than a selective Candida CYP51 inhibitor: it is a useful model for connecting antifungal potency with transporter-mediated drug-interaction evidence. This article presents a DDI-aware framework for assay design, concentration selection, and translational interpretation.

• A40926 Production in Nonomuraea: New Genetic Tools

  2026-09-16

  Yushchuk and colleagues developed promoter-probe and regulatory-engineering tools to improve A40926 glycopeptide antibiotic production in the genetically recalcitrant genus Nonomuraea. The study connects promoter activity, pathway-specific regulator overexpression, and bioreactor evaluation, providing a practical framework for knowledge-based strain improvement.

• From STING Structure to Smarter Cancer Screens

  2026-09-16

  A translational framework for using the L1023 Anti-Cancer Compound Library to connect pathway-level cancer screening with emerging structural insights into STING activation, PI4P biology, and antitumor immunity.

• ApexPrep DNA Plasmid Miniprep Kit for AML Research

  2026-09-15

  Build reproducible plasmid DNA extraction for cloning, sequencing, and LMO2/LDB1 follow-up assays with a workflow designed for both high- and low-copy vectors. The ApexPrep DNA Plasmid Miniprep Kit combines alkaline lysis and membrane binding to produce molecular biology grade plasmid DNA for restriction analysis, transformation, and transfection workflows.

• Capsazepine Workflows for TRPV1 Research

  2026-09-15

  Capsazepine is a practical TRPV1 ion channel antagonist for separating receptor-driven nociception from broader inflammatory and affective pain pathways. This guide covers concentration planning, calcium and electrophysiology assays, TRPM8 controls, apoptosis studies, and troubleshooting for reproducible mechanistic experiments.

7963 records 1/531 page Next 12345 下5页 Last page